GlassScriptPhysician profile
Danya E Neely
NPI 1871059345
$1,185.28
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $437 · 2023: $465 · 2024: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $301.28 | 2022-2024 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Regeneron Healthcare Solutions, INC. | $163.47 | 2022-2024 | Dupixent |
| United Therapeutics Corporation | $80.54 | 2022-2023 | Tyvaso |
| Astrazeneca Pharmaceuticals LP | $78.80 | 2022-2024 | Fasenra, Tagrisso |
| Genzyme Corporation | $61.76 | 2023 | |
| Merck Sharp & Dohme LLC | $56.44 | 2023-2024 | Recarbrio, Zerbaxa |
| Actelion Pharmaceuticals US, INC. | $56.11 | 2024 | Opsumit, Uptravi |
| Electromed, INC. | $55.61 | 2023-2024 | Smartvest |
| Axsome Therapeutics, INC. | $47.96 | 2022-2023 | Sunosi |
| Takeda Pharmaceuticals U.S.A., INC. | $46.73 | 2022-2023 | Glassia |
| Mylan Specialty L.P. | $41.90 | 2022 | |
| Grifols USA, LLC | $39.12 | 2022-2023 | Prolastin-C Liquid |
| Ani Pharmaceuticals, INC. | $37.94 | 2024 | Purified Cortrophin Gel |
| Pulmonx Corporation | $23.58 | 2023 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Baxter Healthcare | $23.47 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $22.97 | 2022 | |
| Glaxosmithkline, LLC. | $16.51 | 2024 | Arexvy, Trelegy Ellipta |
| Amgen INC. | $15.57 | 2024 | Tavneos |
| Bayer Healthcare Pharmaceuticals INC. | $15.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danya Neely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.